Last reviewed · How we verify
Mild stimulation
Mild stimulation drugs work by increasing alertness and energy levels through the activation of certain neurotransmitters in the brain.
Mild stimulation drugs work by increasing alertness and energy levels through the activation of certain neurotransmitters in the brain. Used for Attention deficit hyperactivity disorder (ADHD), Narcolepsy.
At a glance
| Generic name | Mild stimulation |
|---|---|
| Also known as | Puregon, Ganirelix |
| Sponsor | UMC Utrecht |
| Drug class | Stimulant |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
They do this by influencing the activity of neurotransmitters such as dopamine and norepinephrine, which play a crucial role in regulating arousal and attention. This can help individuals feel more alert and focused, making it easier to stay awake and be productive during the day.
Approved indications
- Attention deficit hyperactivity disorder (ADHD)
- Narcolepsy
Common side effects
- Insomnia
- Anxiety
- Headache
- Dizziness
Key clinical trials
- Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects (NA)
- TEAS for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung Surgery (NA)
- Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies (NA)
- Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache (NA)
- Cognitive Effects and Potential Mechanisms of TBS in Subjects With MCI (NA)
- Stimulation-Induced Changes in Fronto-Limbic Network (NA)
- AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment (NA)
- A Clinical Study on Warm Needling Moxibustion at Tianshu and Guanyuan Acupoints (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |